Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest: Afternoon Sessions
3:00:54
Advancing Rare Disease Therapies Through an FDA Rare Disease Innovation Hub
2:08:00
FDA's Final Rule on Requirements for Additional Traceability Records for Certain Foods
3:12:20
Qualifying Biomarkers to Support Rare Disease Regulatory Pathways: Afternoon Sessions
2:16:56
Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence - AM
44:11
Integrating Random Controlled Trials for Drug & Biological Products Into Routine Clinical Practice
17:28
Por qué Alemania no consigue retener a los migrantes cualificados en su país
2:41:13
Natural History Studies and Registries in the Development of Rare Disease Treatments - Morning
57:57